S&P 500   3,692.28 (+0.70%)
DOW   30,141.31 (+0.57%)
QQQ   305.42 (+0.37%)
AAPL   122.03 (-0.74%)
MSFT   214.08 (-0.07%)
FB   280.46 (-0.49%)
GOOGL   1,824.38 (+0.14%)
AMZN   3,176.16 (-0.33%)
TSLA   595.30 (+0.32%)
NVDA   541.21 (+1.00%)
BABA   267.12 (+0.08%)
CGC   28.99 (+1.26%)
GE   10.73 (+1.23%)
MU   73.72 (+5.46%)
AMD   94.03 (+1.86%)
T   29.54 (+1.06%)
NIO   43.30 (-4.52%)
F   9.38 (+1.85%)
ACB   11.97 (+6.49%)
BA   230.92 (-2.65%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.85 (+0.40%)
S&P 500   3,692.28 (+0.70%)
DOW   30,141.31 (+0.57%)
QQQ   305.42 (+0.37%)
AAPL   122.03 (-0.74%)
MSFT   214.08 (-0.07%)
FB   280.46 (-0.49%)
GOOGL   1,824.38 (+0.14%)
AMZN   3,176.16 (-0.33%)
TSLA   595.30 (+0.32%)
NVDA   541.21 (+1.00%)
BABA   267.12 (+0.08%)
CGC   28.99 (+1.26%)
GE   10.73 (+1.23%)
MU   73.72 (+5.46%)
AMD   94.03 (+1.86%)
T   29.54 (+1.06%)
NIO   43.30 (-4.52%)
F   9.38 (+1.85%)
ACB   11.97 (+6.49%)
BA   230.92 (-2.65%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.85 (+0.40%)
S&P 500   3,692.28 (+0.70%)
DOW   30,141.31 (+0.57%)
QQQ   305.42 (+0.37%)
AAPL   122.03 (-0.74%)
MSFT   214.08 (-0.07%)
FB   280.46 (-0.49%)
GOOGL   1,824.38 (+0.14%)
AMZN   3,176.16 (-0.33%)
TSLA   595.30 (+0.32%)
NVDA   541.21 (+1.00%)
BABA   267.12 (+0.08%)
CGC   28.99 (+1.26%)
GE   10.73 (+1.23%)
MU   73.72 (+5.46%)
AMD   94.03 (+1.86%)
T   29.54 (+1.06%)
NIO   43.30 (-4.52%)
F   9.38 (+1.85%)
ACB   11.97 (+6.49%)
BA   230.92 (-2.65%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.85 (+0.40%)
S&P 500   3,692.28 (+0.70%)
DOW   30,141.31 (+0.57%)
QQQ   305.42 (+0.37%)
AAPL   122.03 (-0.74%)
MSFT   214.08 (-0.07%)
FB   280.46 (-0.49%)
GOOGL   1,824.38 (+0.14%)
AMZN   3,176.16 (-0.33%)
TSLA   595.30 (+0.32%)
NVDA   541.21 (+1.00%)
BABA   267.12 (+0.08%)
CGC   28.99 (+1.26%)
GE   10.73 (+1.23%)
MU   73.72 (+5.46%)
AMD   94.03 (+1.86%)
T   29.54 (+1.06%)
NIO   43.30 (-4.52%)
F   9.38 (+1.85%)
ACB   11.97 (+6.49%)
BA   230.92 (-2.65%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.85 (+0.40%)
Log in
NYSE:MET

MetLife Stock Forecast, Price & News

$48.67
+0.96 (+2.01 %)
(As of 12/4/2020 12:51 PM ET)
Add
Compare
Today's Range
$48.05
Now: $48.67
$48.89
50-Day Range
$36.60
MA: $42.63
$48.67
52-Week Range
$22.85
Now: $48.67
$53.28
Volume169,927 shs
Average Volume6.55 million shs
Market Capitalization$43.80 billion
P/E Ratio7.99
Dividend Yield3.86%
Beta1.28
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
MetLife logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 3.0Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.33 out of 5 stars


Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500
Employees49,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$5.98 per share
Book Value$81.75 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Market Cap$43.80 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$48.67
+0.96 (+2.01 %)
(As of 12/4/2020 12:51 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MetLife (NYSE:MET) Frequently Asked Questions

How has MetLife's stock price been impacted by Coronavirus (COVID-19)?

MetLife's stock was trading at $33.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MET stock has increased by 46.2% and is now trading at $48.67.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of MetLife?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for MetLife
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than MetLife?

Wall Street analysts have given MetLife a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MetLife wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is MetLife's next earnings date?

MetLife is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for MetLife
.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) posted its quarterly earnings results on Wednesday, November, 4th. The financial services provider reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.08. The financial services provider had revenue of $16.51 billion for the quarter, compared to analysts' expectations of $16 billion. MetLife had a return on equity of 8.17% and a net margin of 8.82%. The firm's revenue was down 2.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.27 EPS.
View MetLife's earnings history
.

How often does MetLife pay dividends? What is the dividend yield for MetLife?

MetLife announced a quarterly dividend on Tuesday, October 20th. Stockholders of record on Tuesday, November 3rd will be paid a dividend of $0.46 per share on Monday, December 14th. This represents a $1.84 dividend on an annualized basis and a yield of 3.78%. The ex-dividend date of this dividend is Monday, November 2nd.
View MetLife's dividend history
.

What price target have analysts set for MET?

10 brokers have issued 1 year price targets for MetLife's shares. Their forecasts range from $32.00 to $55.00. On average, they expect MetLife's stock price to reach $45.25 in the next year. This suggests that the stock has a possible downside of 7.0%.
View analysts' price targets for MetLife
.

Who are some of MetLife's key competitors?

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MetLife investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), General Electric (GE), International Business Machines (IBM), Exxon Mobil (XOM), Intel (INTC), Johnson & Johnson (JNJ), Cisco Systems (CSCO) and JPMorgan Chase & Co. (JPM).

Who are MetLife's key executives?

MetLife's management team includes the following people:
  • Mr. Michel Abbas Khalaf, CEO, Pres & Director (Age 56, Pay $5.79M)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 46, Pay $3.46M)
  • Mr. Bill Pappas, Exec. VP and Head of Global Technology & Operations (Age 50, Pay $2.3M)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 61, Pay $3.22M)
  • Mr. Ramy Tadros, Exec. VP & Pres of U.S. Bus. (Age 44, Pay $2.6M)
  • Ms. Tamara Lynn Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 48)
  • Mr. Pawan Verma, Exec. VP & Chief Information Officer (Age 43)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations
  • Mr. Stephen W. Gauster, Exec. VP & Gen. Counsel (Age 50)
  • Mr. Randolph J. Clerihue, Chief Communications Officer

What is MetLife's stock symbol?

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are MetLife's major shareholders?

MetLife's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.54%), State Street Corp (3.95%), Diamond Hill Capital Management Inc. (0.77%), Morgan Stanley (0.65%), Charles Schwab Investment Management Inc. (0.61%) and Pzena Investment Management LLC (0.60%). Company insiders that own MetLife stock include Carlos M Gutierrez, Catherine R Kinney, John D Mccallion and Steven J Goulart.
View institutional ownership trends for MetLife
.

Which institutional investors are selling MetLife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, AJO LP, BlackRock Inc., AQR Capital Management LLC, First Trust Advisors LP, Morgan Stanley, Artemis Investment Management LLP, and Allianz Asset Management GmbH. Company insiders that have sold MetLife company stock in the last year include Catherine R Kinney, and Steven J Goulart.
View insider buying and selling activity for MetLife
.

Which institutional investors are buying MetLife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including MUFG Securities EMEA plc, Squarepoint Ops LLC, Caisse DE Depot ET Placement DU Quebec, ExodusPoint Capital Management LP, SPF Beheer BV, Aperio Group LLC, Robeco Institutional Asset Management B.V., and Crestline Management LP.
View insider buying and selling activity for MetLife
.

How do I buy shares of MetLife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MetLife's stock price today?

One share of MET stock can currently be purchased for approximately $48.67.

How big of a company is MetLife?

MetLife has a market capitalization of $43.80 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. MetLife employs 49,000 workers across the globe.

What is MetLife's official website?

The official website for MetLife is www.metlife.com.

How can I contact MetLife?

MetLife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.